Atherosclerosis is the main underlying pathology for many cardiovascular diseases (CVDs),
which are the leading cause of death globally and represent a serious health crisis …

Drug-Eluting Coronary-Artery Stents | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

With the recent advancement of nanomaterials and nanostructured materials, the point-of-
care biosensor devices have shown a potential growth to revolutionize the future …

Aims Long-term disease progression following myocardial infarction (MI) is not well
understood. We examined the risk of subsequent cardiovascular events in patients …

Background In patients with stable coronary artery disease, it remains unclear whether an
initial management strategy of percutaneous coronary intervention (PCI) with intensive …

Aims The aims of the Swedish Web-system for Enhancement and Development of Evidence-
based care in Heart disease Evaluated According to Recommended Therapies …

Randomized clinical trials provide the foundation of clinical evidence to guide physicians in
their selection of treatment options. Importantly, randomization is the only reliable method to …

Objectives: This study sought to compare the risk of stent thrombosis among patients treated
with bare-metal stents (BMS), first-generation drug-eluting stents (G1-DES), and second …

Background Whether the two drug-eluting stents approved by the US Food and Drug
Administration—a sirolimus-eluting stent and a paclitaxel-eluting stent—are associated with …